Exercise stress test results in patients with bare metal stents or drug-eluting stents: Pathophysiological and clinical implications

Circulation Journal

Volumn 74, Issue 11, 2010, Pages 2372-2378

  Nerla, Roberto ^a   di Monaco, Antonio ^a   Sgueglia, Gregory A ^a   Battipaglia, Irma ^a   Careri, Giulia ^a   Pinnacchio, Gaetano ^a   Tarzia, Pierpaolo ^a   Lanza, Gaetano Antonio ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Coronary stent implantation; Exercise stress testing; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METAL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78349240831     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0379     Document Type: Article

References (32)

1. Maluenda G, Lemesle G, Waksman R. A critical appraisal of the safety and efficacy of drug-eluting stents. Clin Pharmacol Ther 2009; 85: 474-480.
2. Takano M, Mizuno K. Coronary angioscopic evaluation for serial changes of luminal appearance after pharmacological and catheter interventions. Circ J 2010; 74: 240-245.
3. Honda Y. Drug-eluting stents: Insights from invasive imaging technologies. Circ J 2009; 73: 1371-1380.
4. Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009; 73: 615-621.
5. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007; 370: 937-948.
6. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
7. Gaku N, Kengo T, Aoki J, Onuma Y, Yamamoto H, Higashikuni Y, et al. Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J 2006; 70: 1367-1371.
8. Kataoka Y, Yasuda S, Morii I, Kawamura A, Miyazaki S. Improved long-term prognosis of elderly women in the era of sirolimus-eluting stents. Circ J 2009; 73: 1219-1227.
9. Park KW, Kang SH, Chung WY, Lee HY, Park JS, Kang HJ, et al. Real world comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. Circ J 2010; 74: 1111-1112.
10. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-959.
11. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
12. Stahli BE, Camici GG, Steffel J, Akhmedov A, Shojaati K, Graber M, et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res 2006; 99: 149-155.
13. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051-1058.
14. Muhlestein JB. Endothelial dysfunction associated with drug-eluting stents what, where, when, and how? J Am Coll Cardiol 2008; 51: 2139-2140.
15. Togni M, Räber L, Cocchia R, Wenaweser P, Cook S, Windecker S, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2007; 120: 212-220.
16. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al; RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
17. Epstein SE, Cannon RO 3rd, Bonow RO. Exercise testing in patients with microvascular angina. Circulation 1991; 83: III-73-III-76.
18. Hiasa K, Takemoto M, Matsukawa R, Matoba T, Kuga T, Sunagawa K. Chest pain without significant coronary stenosis after implantation of Sirolimus-eluting stents. Inter Med 2009; 48: 213-217.
19. Caramori PR, Lima VC, Seidelin PH, Newton GE, Parker JD, Adelman AG. Long-term endothelial dysfunction after coronary artery stenting. J Am Coll Cardiol 1999; 34: 1675-1679.
20. Lerman A, Eeckhout E. Coronary endothelial dysfunction following sirolimus-eluting stent placement: Should we worry about it? Eur Heart J 2006; 27: 125-126.
21. Camici GG, Steffel J, Amanovic I, Breitenstein A, Baldinger J, Keller S, et al. Rapamycin promotes arterial thrombosis in vivo: Implications for everolimus and zotarolimus eluting stents. Eur Heart J 2010; 31: 236-242.
22. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L; SCAAR Study Group. Long-term outcomes with drugeluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019.
23. Roukoz H, Bavry AA, Sarkees ML, Mood GR, Kumbhani DJ, Rabbat MG, et al. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med 2009; 122: 581.e1-e10.
24. Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, et al. Use of drug-eluting stents in acute myocardial infarction: A systematic review and meta-analysis. J Am Coll Cardiol 2009; 53: 1677-1689.
25. Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, et al; DES.DE Study Group. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol 2009; 104: 1362-1369.
26. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
27. Massa D, Pirelli S, Gara E, Faletra F, Alberti A, Piccalò G, et al. Exercise testing and dipyridamole echocardiography test before and 48 h after successful coronary angioplasty: Prognostic implications. Eur Heart J 1989; 10: 13-17.
28. Laarman G, Luijten HE, van Zeyl LG, Beatt KJ, Tijssen JG, Serruys PW, et al. Assessment of "silent" restenosis and long-term follow-up after successful angioplasty in single vessel coronary artery disease: The value of quantitative exercise electrocardiography and quantitative coronary angiography. J Am Coll Cardiol 1990; 16: 578-585.
29. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002; 40: 1531-1540.
30. Wenaweser P, Surmely JF, Windecker S, Roffi M, Togni M, Billinger M, et al. Prognostic value of early exercise testing after coronary stent implantation. Am J Cardiol 2008; 101: 807-811.
31. el-Tamimi H, Davies GJ, Hackett D, Fragasso G, Crea F, Maseri A. Very early prediction of restenosis after successful coronary angioplasty: Anatomic and functional assessment. J Am Coll Cardiol 1990; 15: 259-264.
32. Babapulle MN, Diodati JG, Blankenship JC, Huynh T, Cugno S, Puri R, et al. Utility of routine exercise treadmill testing early after percutaneous coronary intervention. BMC Cardiovasc Disord 2007; 7: 12-19.